REACT: Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia

Sponsor
Fondazione IRCCS San Gerardo dei Tintori (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05986032
Collaborator
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (Other), University Children's Hospital Basel (Other), Uppsala University Hospital (Other), Medical University of Vienna (Other), Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) (Other)
150
6
23
25
33.1

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about the correlation between respiratory system reactance, as assessed by respiratory oscillometry, and respiratory outcomes in preterm infants born before 32 weeks of gestation. The main question it aims to answer is if the reactance z-score at 7 postnatal days adds to relevant clinical factors in the prediction of bronchopulmonary dysplasia. Participants will receive respiratory oscillometry measurements at 7 ± 2 postnatal days.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Respiratory Oscillometry

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Relationship Between Respiratory System Reactance Assessed by Respiratory Oscillometry and Respiratory Outcomes in Very Preterm Infants
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 3, 2023
Anticipated Study Completion Date :
Sep 24, 2023

Arms and Interventions

Arm Intervention/Treatment
no bronchopulmonary dysplasia

Group of patients who do not receive the diagnosis of bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-mentrual age

Diagnostic Test: Respiratory Oscillometry
Measurement of respiratory system reactance by respiratory oscillometry

bronchopulmonary dysplasia

Group of patients developing bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-menstrual age.

Diagnostic Test: Respiratory Oscillometry
Measurement of respiratory system reactance by respiratory oscillometry

Outcome Measures

Primary Outcome Measures

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure [Xrs will be measured at 7 days of life]

    Xrs will be expressed in z-score using reference equation for very preterm infants

Secondary Outcome Measures

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure and ± 2 cmH2O [Xrs will be measured at 7 days of life]

    Xrs will be expressed in cmH2O*S/L

Other Outcome Measures

  1. Respiratory support mode [7 postnatal days]

    Respiratory support mode will be coded as 0 = no respiratory support, 1 = nasal high flow therapy, 2 = nasal CPAP or nasal IPPV, 3 = invasive mechanical ventilation

  2. Fraction of inspired oxygen [7 days of life]

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Days to 9 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • born before 32 weeks post-menstrual age
Exclusion Criteria:
  • congenital abnormalities

  • Inherited disorders of metabolism

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Vienna Vienna Wien Austria 1090
2 Fondazione IRCCS San Gerardo dei Tintori Monza Monza E Brianza Italy 20900
3 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano Italy 20122
4 Amsterdam UMC Amsterdam Netherlands
5 Uppsala University Children's Hospital Uppsala Sweden S-751 85
6 Universitäts-Kinderspital beider Basel Basel Switzerland 4056

Sponsors and Collaborators

  • Fondazione IRCCS San Gerardo dei Tintori
  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
  • University Children's Hospital Basel
  • Uppsala University Hospital
  • Medical University of Vienna
  • Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Investigators

  • Principal Investigator: Camilla Rigotti, PhD, Fondazione IRCCS San Gerardo dei Tintori

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fondazione IRCCS San Gerardo dei Tintori
ClinicalTrials.gov Identifier:
NCT05986032
Other Study ID Numbers:
  • REACT
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Fondazione IRCCS San Gerardo dei Tintori
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 14, 2023